The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, ...

Nicholas Kristof is right to call for more treatment and prevention. However, by suggesting that drug decriminalization was ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...

Drug overdose deaths in the U.S. declined from 2022 to 2023, the first decrease since the COVID-19 pandemic, according to data from the CDC. The age-adjusted rate of overdose deaths fell 4.0% from ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed ...

President Donald Trump’s 10% tariff rule on China could delay several pharmaceutical drugs imported to the US that many ...

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

Preparation of a dose of Buprenorphine, an opioid that can be administered to people with opioid-use disorder to blunt ...

Signals™ Notebook, the premier SaaS Electronic Laboratory Notebook used by 1 million scientists and powered by ChemDraw™ ...